Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs…
Granted Indian Patent for its MyoVista® Wavelet Technology Southlake, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence…
AI is about to make a big debut in hospitals Photo by National Cancer Institute on Unsplash If you’ve ever been to a hospital, you’ve probably seen an ECG (electrocardiograph). It’s the pulse-measuring…
By Tom White, Benzinga Contributor It's unsurprising to reveal that heart disease is one of the leading causes of death worldwide, with more than 50,000 deaths daily attributed to various…
Patent covers use of AI-ECG for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease Source: Heart Test Laboratories, Inc. Southlake,…
For HeartSciences CEO Andrew Simpson, the pandemic's fallout only underscores the urgent need for better cardiac diagnostic tools. HeartSciences Bets Big on AI Amid Surging Heart Disease Deaths In a…
